RenovoRx CEO Issues Update Letter to Shareholders marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.
Data shows that the Trans-Arterial Micro-Perfusion platform increases intra-arterial pressure, improving drug delivery with 100-fold increase local tissue concentration of the therapy
TAMP offers.
Research Supports RenovoRx’s Lead Oncology Product Candidate, RenovoGem, and its Novel Therapy Platform, TAMP, for the Treatment of Locally Advanced Pancreatic Cancer
Clinical Data Abstract Presentation; IP Portfolio of 9 Patents; Phase 3 Cancer Treatments: RenovoRx NASDAQ: RNXT $RNXT einnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from einnews.com Daily Mail and Mail on Sunday newspapers.
RenovoRx Announces Clinical Data Abstract at the 2024 Society of Interventional Radiology Annual Scientific Meeting streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.